Recently, the three types of PTCA balloon catheters developed independently by Kossel – Selethru II (SC, NC26, Super NC) – have obtained the certificate from the KFDA.

Until now, the Selethru PTCA balloon catheter has been approved for sale in Asia, the Middle East, South America, and other regions. With its outstanding clinical performance, it has gained recognition.
In response to the different clinical needs in South Korea, Kossel responded promptly and upgraded the Selethru PTCA balloon catheter. We customized it and launched the Selethru II (SC, NC26, Super NC) PTCA balloon catheter. Among them, the Selethru II Super NC has a maximum burst pressure of up to 36 atm, which will bring a better surgical experience to local surgeons and also help the company further expand the Asian market and bring hope to more patients.
In the future, Kossel will continue to strive to promote high-quality medical devices from China to more countries around the world, benefiting more patients globally.